Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
Body unavailable. Use the original source.
Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.